3-(1-PYRROLIDINYL)-8-AZABICYCLO[3.2.1]OCTANE
![]() |
- $110 - $802.73
- Product name: 3-(1-PYRROLIDINYL)-8-AZABICYCLO[3.2.1]OCTANE
- CAS: 1185300-31-5
- MF: C11H20N2
- MW: 180.2899
- EINECS:
- MDL Number:MFCD18459196
- Synonyms:3-(1-Pyrrolidinyl)-8-azabicyclo[3.2.1]octanedihydrochloride;3-(1-PYRROLIDINYL)-8-AZABICYCLO[3.2.1]OCTANE
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
- TRC
Package
- 50mg
- 500mg
- ManufacturerAK Scientific
- Product number0391AD
- Product description3-(1-Pyrrolidinyl)-8-azabicyclo[3.2.1]octanedihydrochloride
- Packaging500mg
- Price$326
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0084560
- Product description3-(1-PYRROLIDINYL)-8-AZABICYCLO[3.2.1]OCTANE DIHYDROCHLORIDE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number021801
- Product description3-(1-Pyrrolidinyl)-8-azabicyclo[3.2.1]octanedihydrochloride
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP999645
- Product description3-(1-Pyrrolidinyl)-8-azabicyclo[3.2.1]octaneDihydrochloride
- Packaging50mg
- Price$110
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 0391AD | 3-(1-Pyrrolidinyl)-8-azabicyclo[3.2.1]octanedihydrochloride | 500mg | $326 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0084560 | 3-(1-PYRROLIDINYL)-8-AZABICYCLO[3.2.1]OCTANE DIHYDROCHLORIDE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
Matrix Scientific | 021801 | 3-(1-Pyrrolidinyl)-8-azabicyclo[3.2.1]octanedihydrochloride | 500mg | $205 | 2021-12-16 | Buy |
TRC | P999645 | 3-(1-Pyrrolidinyl)-8-azabicyclo[3.2.1]octaneDihydrochloride | 50mg | $110 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|